Actively Recruiting
Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Cardiac Arrest
Led by AfterROSC · Updated on 2025-10-03
4500
Participants Needed
5
Research Sites
269 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Even in patients with successful return of spontaneous circulation (ROSC), outcome after cardiac arrest remains poor. The overall in-hospital survival rate widely varies both worldwide and across communities, from 1 to 4 folds according to circumstances of arrest and post-resuscitation interventions. Several studies have already shown that early interventions performed after ROSC, such as treatment of the cause, targeted temperature management, optimal hemodynamic management and extra-corporeal life support in selected patients, could improve the outcome in post-cardiac arrest patients. However, the decision process regarding the allocation of these resources, in parallel with the management of patients' proxies, remains a complex challenge for physicians facing these situations. Consequently, several prediction models and scores have been developed in order to stratify the risk of unfavorable outcome and to discriminate the best candidates for post-resuscitation interventions. Overall, several scores exist, but external validation are lacking and direct comparisons are needed to assess relative interest of scoring systems. Indeed, establishing the optimal scoring system is crucial, for optimal treatment allocation and appropriate information to relatives.
CONDITIONS
Official Title
Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Cardiac Arrest
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients admitted to intensive care after cardiac arrest, including both in-hospital and out-of-hospital arrests
- Comatose on admission, defined by a Glasgow Coma Scale score of 8 or less
You will not qualify if you...
- Cardiac arrest occurring inside the hospital
- Patients under 18 years old
- Patients under legal guardianship
- Protected persons
- Patients previously included in this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
CHU Nantes
Nantes, Pays de Loire, France
Actively Recruiting
2
Hopital Jacques Cartier
Massy, France
Actively Recruiting
3
Clinique Ambroise Paré
Neuilly-sur-Seine, France
Actively Recruiting
4
APHP, Cochin
Paris, France
Actively Recruiting
5
CH Versailles
Versailles, France
Actively Recruiting
Research Team
J
Jean Baptiste Lascarrou, MD, PhD
CONTACT
A
Alain Cariou, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here